Logo

Ocimum to Provide Microarray Analysis for Hospital of Joint Diseases

Jul 07, 2003

NEW YORK, July 7 - Bioinformatics startup Ocimum Biosolutions said today that it is collaborating with the Hospital of Joint Diseases at New York University's School of Medicine to analyze musculoskeletal disease data.

 

Ocimum will use its microarray analysis software Genowiz in the project.

 

Financial terms and other details of the project were not disclosed.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.